SUNNYVALE, Calif., Oct. 31, 2013 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today a $39,590 contract award from the United States Department of Veteran Affairs (VA). The VA Healthcare System provides some of the world's finest medicine and cutting-edge technology, as well as a teaching hospital, a full range of patient care services and research in the areas of medicine, surgery, psychiatry, rehabilitation, neurology, oncology, dentistry, geriatrics, and extended care.
The Veteran Affairs Hospital purchased the Arrayit Colorimetric Protein Microarray Platform I, which includes a microarray printer, microarray scanner, tools, kits, reagents and consumables for rapid and affordable protein microarray experimentation. Arrayit protein microarray technology empowers the Veterans Administration's mission of advanced research in geriatrics, mental health, Alzheimer's disease, spinal cord regeneration, schizophrenia, rehabilitation, HIV research, health economics, and other areas critical to our veterans.
Arrayit's tagline "Powerful Science for Life" is consistent with the VA mission statement of fulfilling President Abraham Lincoln's promise "To care for him who shall have borne the battle, and for his widow, and his orphan" by serving and honoring the men and women who are America's veterans. ARYC will fulfill the contract during the fourth quarter of this year.
About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
- Powerful Science for Life
Visit http://arrayit.com/ for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for the quarterly period ended June 30, 2013.
CONTACT: Media Contact John Nesbett Institutional Marketing Services 203.972.9200 JNesbett@InstitutionalMS.com